Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? (Deficit) Equity - Stock Options (Details)

v3.20.1
Stockholders’ (Deficit) Equity - Stock Options (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Equity [Abstract]    
Outstanding (in shares) 2,883,550  
Granted (in shares) 387,500  
Outstanding (in shares) 3,271,050 2,883,550
Exercisable (in shares) 968,950  
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 2.70  
Granted (in dollars per share) 11.74  
Outstanding, Weighted Average Exercise Price (in dollars per share) 3.77 $ 2.70
Exercisable (in dollars per share) $ 1.74  
Outstanding, Weighted Average Remaining Life (Year) 8 years 6 months 10 days 8 years 7 months 13 days
Exercisable, Weighted Average Remaining Life (Year) 8 years 5 months 12 days  
Outstanding, Aggregate Intrinsic Value $ 15,391,278 $ 23,861,981
Exercisable, Aggregate Intrinsic Value $ 6,528,096